(Q33693936)

English

Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

author name string

Rui-Qing Peng

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Xiao-Jun Wu

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Ya Ding

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Chun-Yan Li

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Xing-Juan Yu

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Xing Zhang

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Zhi-Zhong Pan

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

De-Sen Wan

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Li-Ming Zheng

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yi-Xin Zeng

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Xiao-Shi Zhang

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

0 references

publication date

16 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

496

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-10-496

0 references

HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Non-histone nuclear factor HMGB1 is phosphorylated and secreted in colon cancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

The diagnosis of colorectal cancer in patients with symptoms: finding a needle in a haystack

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Immunogenic and tolerogenic cell death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Migration, maintenance and recall of memory T cells in peripheral tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

The localization and density of immune cells in primary tumors of human metastatic colorectal cancer shows an association with response to chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Immunogenic cell death modalities and their impact on cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

The immunogenicity of tumor cell death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

HMGB1: a two-headed signal regulating tumor progression and immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Immunogenic cancer cell death: a key-lock paradigm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Immunogenic anti-cancer chemotherapy as an emerging concept

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

HMGB1: endogenous danger signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Effector memory alphabeta T lymphocytes can express FcgammaRIIIa and mediate antibody-dependent cellular cytotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Immunogenicity of anthracyclines: moving towards more personalized medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

RAGE and RAGE ligands in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

E-selectin regulates gene expression in metastatic colorectal carcinoma cells and enhances HMGB1 release

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

HMGB1 develops enhanced proinflammatory activity by binding to cytokines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Growth suppression and radiosensitivity increase by HMGB1 in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Masquerader: high mobility group box-1 and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

The adaptive immunologic microenvironment in colorectal cancer: a novel perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: preliminary observations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

High-mobility group box 1 (HMGB1) protein: friend and foe.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

The cytokine activity of HMGB1--extracellular escape of the nuclear protein.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Effector memory T cells, early metastasis, and survival in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Hmgb-1 as a therapeutic target for infectious and inflammatory disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Systemic therapy for colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Depletion of tumor-infiltrating macrophages is associated with amphoterin expression in colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Differential effects between amphoterin and advanced glycation end products on colon cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Preferential localization of effector memory cells in nonlymphoid tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949807

21 June 2018

The essential role of the in situ immune reaction in human colorectal cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-496

21 January 2018

Coordination of intratumoral immune reaction and human colorectal cancer recurrence.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-496

21 January 2018

Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-496

21 January 2018

Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-496

21 January 2018

Memory CD8 T-cell compartment grows in size with immunological experience

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-496

21 January 2018

Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon c

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-496

21 January 2018

Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial).

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-496

21 January 2018

HMGB1 is a bone-active cytokine.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-496

21 January 2018

High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-496

21 January 2018

Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-496

21 January 2018

Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-496

21 January 2018

Overexpression of high mobility group (HMG) B1 and B2 proteins directly correlates with the progression of squamous cell carcinoma in skin.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-496

21 January 2018

Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-496

21 January 2018

High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-496

21 January 2018

Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20846416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of dendritic cells by HMGB1 is associated with lymph node metastasis of human colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20846416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The expression of high-mobility group protein box 1 correlates with the progression of non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20846416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/reperfusion injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/20846416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20846416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HMGB1 attenuates anti-metastatic defense of the lymph nodes in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20846416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variation of HMGB1 expression in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20846416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20846416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-10-496

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-10-496

9 September 2019

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33693936&oldid=1534666979"